WebINCY Price $73.62 Fair Value Price $86.91 Market Cap $16.41B 52 Week Low $65.07 52 Week High $86.29 P/E 48.12x P/B 3.76x P/S 5.25x PEG 0.66x Dividend Yield N/A Revenue $3.39B Earnings $340.66M Gross Margin 93.9% Operating Margin 15.67% Profit Margin 10% Debt to Equity 0.34 Operating Cash Flow $970M Beta 0.72 Next Earnings May 1, 2024 Ex … WebJan 18, 2024 · Incyte Corp (INCY) $74.22 0.60 (0.81%) 16:00 EDT INCY Stock Quote Delayed 30 Minutes 7 Biotech Stocks That Will Make You Rich in 10 Years By Josh Enomoto, InvestorPlace Contributor Jan...
Incyte Corp. Common Stock (INCY) Pre-Market Quotes Nasdaq
WebReal Time Quote About Incyte Corp. Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. WebAug 30, 2024 · INCY INVESTING Mar 19, 2024 12:13 PM EDT Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial Incyte's Phase 3 study of ruxolitinib missed its primary … philip silano port chester
Incyte Corporation (INCY) Stock Historical Prices & Data - Yahoo …
WebReal Time Quote About Incyte Corp. Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary … WebApr 15, 2024 · NasdaqGS:INCY Earnings Per Share Growth April 15th 2024. This free interactive report on Incyte's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. A Different Perspective. While the broader market lost about 6.7% in the twelve months, Incyte shareholders did even worse, losing 8.9%. WebINCY, Incyte Corporation - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines ... (INCY) - DEVELOPS SMALL MOLECULE DRUGS TO TREAT CANCER AND INFLAMMATORY DISEASES. GROUP LEADERSHIP. Medical-Biomed/Biotech Group. INCY. is ranked # 22. truth social posts